DE3368631D1 - Quinazoline cardiac stimulants - Google Patents

Quinazoline cardiac stimulants

Info

Publication number
DE3368631D1
DE3368631D1 DE8383302529T DE3368631T DE3368631D1 DE 3368631 D1 DE3368631 D1 DE 3368631D1 DE 8383302529 T DE8383302529 T DE 8383302529T DE 3368631 T DE3368631 T DE 3368631T DE 3368631 D1 DE3368631 D1 DE 3368631D1
Authority
DE
Germany
Prior art keywords
quinazoline
cardiac stimulants
stimulants
cardiac
quinazoline cardiac
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8383302529T
Other languages
English (en)
Inventor
Simon Fraser Dr Campbell
David Anthony Dr Roberts
John Kendrick Dr Stubbs
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Ltd
Pfizer Corp
Original Assignee
Pfizer Ltd
Pfizer Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ltd, Pfizer Corp filed Critical Pfizer Ltd
Application granted granted Critical
Publication of DE3368631D1 publication Critical patent/DE3368631D1/de
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/15Six-membered rings
    • C07D285/16Thiadiazines; Hydrogenated thiadiazines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE8383302529T 1982-05-15 1983-05-05 Quinazoline cardiac stimulants Expired DE3368631D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8214206 1982-05-15

Publications (1)

Publication Number Publication Date
DE3368631D1 true DE3368631D1 (de) 1987-02-05

Family

ID=10530384

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8383302529T Expired DE3368631D1 (de) 1982-05-15 1983-05-05 Quinazoline cardiac stimulants

Country Status (22)

Country Link
US (1) US4489075A (de)
EP (1) EP0094766B1 (de)
JP (1) JPS58208289A (de)
KR (1) KR840004747A (de)
AU (1) AU538171B2 (de)
CA (1) CA1195977A (de)
DD (2) DD210269A5 (de)
DE (1) DE3368631D1 (de)
DK (1) DK210183A (de)
ES (3) ES522278A0 (de)
FI (1) FI831684L (de)
GR (1) GR77498B (de)
IL (1) IL68668A0 (de)
IN (1) IN160680B (de)
NO (1) NO831728L (de)
NZ (1) NZ204225A (de)
PH (1) PH18763A (de)
PL (2) PL247054A1 (de)
PT (1) PT76687B (de)
SU (1) SU1194257A3 (de)
YU (1) YU105083A (de)
ZA (1) ZA833422B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8320958D0 (en) * 1983-08-03 1983-09-07 Pfizer Ltd Quinazoline cardiac stimulants
JPS61215389A (ja) * 1985-03-20 1986-09-25 Kyowa Hakko Kogyo Co Ltd キナゾリン誘導体およびそれを含有する強心剤
US5138062A (en) * 1989-10-03 1992-08-11 Philip Morris Incorporated Nicotine analogs
ATE231505T1 (de) * 1991-03-28 2003-02-15 Eisai Co Ltd Neue heterocyclische/cyclische amine
MX371014B (es) * 2014-05-15 2020-01-10 Pfizer Forma cristalina de 6-[(4r)-4-metil-1,2-dióxido-1,2,6-tiadiazinan- 2-il]isoquinolin-1-carbonitrilo.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3971783A (en) * 1973-03-07 1976-07-27 Pfizer Inc. 4-Aminoquinazoline derivatives as cardiac stimulants
GB1460389A (en) * 1974-07-25 1977-01-06 Pfizer Ltd 4-substituted quinazoline cardiac stimulants
US4171363A (en) * 1977-02-22 1979-10-16 Bristol-Myers Company 1,2,3-Thiadiazole process
CA1086735A (en) * 1977-11-03 1980-09-30 John C. Danilewicz Piperidino-quinazolines

Also Published As

Publication number Publication date
FI831684A0 (fi) 1983-05-13
SU1194257A3 (ru) 1985-11-23
IL68668A0 (en) 1983-09-30
EP0094766A2 (de) 1983-11-23
ES8504793A1 (es) 1985-05-01
EP0094766A3 (en) 1984-12-12
ES8504794A1 (es) 1985-05-01
NO831728L (no) 1983-11-16
DD210269A5 (de) 1984-06-06
ES528482A0 (es) 1985-05-01
NZ204225A (en) 1985-12-13
EP0094766B1 (de) 1986-12-30
AU1452283A (en) 1983-11-17
DD216018A5 (de) 1984-11-28
YU105083A (en) 1986-02-28
PT76687A (en) 1983-06-01
GR77498B (de) 1984-09-24
ES8407039A1 (es) 1984-08-16
IN160680B (de) 1987-07-25
PL241968A1 (en) 1984-08-13
DK210183D0 (da) 1983-05-11
DK210183A (da) 1983-11-16
FI831684L (fi) 1983-11-16
JPS58208289A (ja) 1983-12-03
KR840004747A (ko) 1984-10-24
AU538171B2 (en) 1984-08-02
PH18763A (en) 1985-09-20
ES522278A0 (es) 1984-08-16
CA1195977A (en) 1985-10-29
PL247054A1 (en) 1985-03-26
ZA833422B (en) 1984-02-29
ES528481A0 (es) 1985-05-01
PT76687B (en) 1986-03-27
US4489075A (en) 1984-12-18

Similar Documents

Publication Publication Date Title
FI834073A (fi) Minimering av verkningarna av vridvibrationer i vindturbiner
DE3372919D1 (de) Bioelectrode
FI834235A0 (fi) Anordning foer placering av koniska foeremaol i en laoda
FI832876A0 (fi) Foerfarande foer foerhindrande av oavsiktligt kritiskt tillstaond i en kaernbraensledriven elkraftgenererande enhet
DE3472677D1 (de) Quinazoline cardiac stimulants
FI833947A (fi) Kontroll av trycket i vaetskestroemkretsar
IT1169734B (it) Pirazolopiridin derivato
DE3368631D1 (de) Quinazoline cardiac stimulants
FR2519243B1 (fr) Rayonnage
IT1135323B (it) Filatoio di preparazione
AT388238B (de) Schusswaffe
NO152387C (no) Undervisningsbord
FI821874A0 (fi) Tak- eller vaeggkonstruktion
AT388449B (de) Schusswaffe
FI823441A (fi) Foerfarande foer framstaellning av lignosulfonatbaserade blandningar foer anvaendning i synnerhet stillsatsaemnen foer betong
FI820793A (fi) Foerfarande foer instaellning av aendlappar i aendorna av foerpackade rullorna i foerpackningslinje
FI824181L (fi) Foerfarande foer invaendig rengoering av metallroer i ringform
RO85068A3 (ro) Inima artificiala
RO83132A2 (ro) Electrostimulator cardiac
BR6302003U (pt) Bioprotese cardiaca
ES255230Y (es) Horma extensible mejorada
FI821008A0 (fi) Bandstraeckningssystem foer last
FI65884B (fi) Anordning foer reglering av en traktors dragstaenger i sidled
BR8604945A (pt) Cineprojetora diametral
DK66983D0 (da) Hjertefunktionsproeveapparat

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee